Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-week Pilot Study to Investigate the Effects of Protein Hydrolysate From Blue Whiting on Glucose Regulation, Inflammation and Serum Lipids in Elderly Nursing Home Residents From Western Norway

NCT03529344 is registered in ClinicalTrials.gov with University of Bergen as lead sponsor.

NCT NCT03529344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03529344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-week Pilot Study to Investigate the Effects of Protein Hydrolysate From Blue Whiting on Glucose Regulation, Inflammation and Serum Lipids in Elderly Nursing Home Residents From Western Norway
Lead sponsor
University of Bergen
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2016
Completion date
December 31, 2021
Enrollment
24 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aging, blood sugar; high, inflammation, muscle loss, muscle weakness